Use of a Genetic Variant Related to Circulating FXa (Activated Factor X) Levels to Proxy the Effect of FXa Inhibition on Cardiovascular Outcomes
Dipender Gill, Stephen Burgess
Topics & Concepts
BiostatisticsEpidemiologyMedicinePublic healthProxy (statistics)Family medicineInternal medicinePathologyMachine learningComputer scienceAtrial Fibrillation Management and OutcomesCardiac Arrhythmias and TreatmentsCoagulation, Bradykinin, Polyphosphates, and Angioedema